GB0426393D0 - Materials and methods relating to modulators of spindle checkpoint kinases - Google Patents
Materials and methods relating to modulators of spindle checkpoint kinasesInfo
- Publication number
- GB0426393D0 GB0426393D0 GBGB0426393.5A GB0426393A GB0426393D0 GB 0426393 D0 GB0426393 D0 GB 0426393D0 GB 0426393 A GB0426393 A GB 0426393A GB 0426393 D0 GB0426393 D0 GB 0426393D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- modulators
- materials
- methods relating
- spindle checkpoint
- checkpoint kinases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0426393.5A GB0426393D0 (en) | 2004-12-01 | 2004-12-01 | Materials and methods relating to modulators of spindle checkpoint kinases |
PCT/GB2005/004622 WO2006059121A2 (en) | 2004-12-01 | 2005-12-01 | Modulators of spindle checkpoint kinases and a taxol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0426393.5A GB0426393D0 (en) | 2004-12-01 | 2004-12-01 | Materials and methods relating to modulators of spindle checkpoint kinases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0426393D0 true GB0426393D0 (en) | 2005-01-05 |
Family
ID=34043885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0426393.5A Ceased GB0426393D0 (en) | 2004-12-01 | 2004-12-01 | Materials and methods relating to modulators of spindle checkpoint kinases |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0426393D0 (en) |
WO (1) | WO2006059121A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101357038B1 (en) * | 2004-12-08 | 2014-02-03 | 아벤티스 파마슈티칼스 인크. | Method for measuring resistance or sensitivity to docetaxel |
US20100233689A1 (en) | 2007-03-22 | 2010-09-16 | The General Hospital Corporation | Pyrazoloanthrone and derivatives thereof for the treatment of cancer expressing 'mullerian inhibiting substance' type ii receptor (misrii) and of excess androgen states |
TW201102081A (en) | 2009-05-11 | 2011-01-16 | Oncotherapy Science Inc | TTK peptides and vaccines including the same |
-
2004
- 2004-12-01 GB GBGB0426393.5A patent/GB0426393D0/en not_active Ceased
-
2005
- 2005-12-01 WO PCT/GB2005/004622 patent/WO2006059121A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006059121A2 (en) | 2006-06-08 |
WO2006059121A3 (en) | 2007-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200700527B (en) | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof | |
HK1126474A1 (en) | Novel pyridopyrazines and their use as modulators of kinases | |
IL181524A0 (en) | Heterocyclic compounds and methods of use | |
IL176958A0 (en) | Compounds and methods of use | |
SI1984353T1 (en) | Aurora kinase modulators and method of use | |
IL185914A0 (en) | Pyrimidine compounds and methods of use | |
EP1751124A4 (en) | Raf modulators and methods of use | |
IL213843A0 (en) | 4-aminotetracyclines and methods of use thereof | |
HK1167140A1 (en) | Aurora kinase modulators and method of use | |
ZA200900058B (en) | Superabrasive materials and methods of manufacture | |
IL192129A0 (en) | Anti-mn antibodies and methods of using same | |
IL178161A0 (en) | Bonded thin-film structures for optical modulators and methods of manufacture | |
IL186970A0 (en) | Thiazole compounds and methods of use | |
EP1893607A4 (en) | Inhibitors of checkpoint kinases | |
EP1874759A4 (en) | C-met modulators and methods of use | |
IL186342A0 (en) | Spirocyclic heterocycic derivaives and methods of their use | |
EP1678168A4 (en) | P70s6 kinase modulators and method of use | |
ZA200607582B (en) | Anti-parasitic compounds and methods of their use | |
HK1135099A1 (en) | Aza-indolyl compounds and methods of use | |
EP2021555A4 (en) | Structural element and methods of use thereof | |
EP1913390A4 (en) | Assay particles and methods of use | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
GB2440843B (en) | Liquid sealant and methods of use | |
EP1812451A4 (en) | Compounds and methods of use thereof | |
GB2428394B (en) | A device for holding a column or cartridge in proximity to a detector and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |